Normal nigrostriatal innervation but dopamine dysfunction in mice carrying hypomorphic tyrosine hydroxylase alleles
- 1 April 2003
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 72 (4) , 444-453
- https://doi.org/10.1002/jnr.10606
Abstract
We investigated the use of the mouse tyrosine hydroxylase (TH) gene to drive knock-in constructs in catecholaminergic neurons. Two targeting constructs representing truncated forms of either of the BMP receptors ALK-2 or BMPR-II preceded by an internal ribosome entry site (IRES) were introduced into the 3' untranslated region of TH. An frt-flanked neomycin-resistance (neo(r)) cassette was placed in the 3' end of the targeting constructs. Mice homozygous for the knock-in alleles showed various degrees of hypokinetic behavior, depending mainly on whether the neo(r) cassette was removed. In situ hybridization and immunohistochemistry showed that TH mRNA and protein were variously down-regulated in these mouse strains. Reduced levels of dopamine and noradrenalin were found in several brain areas. However, number and morphology of neurons in substantia nigra and their projections to striatum appeared normal in the neo(r)-positive TH hypomorphic mice as examined by markers for L-aromatic amino acid decarboxylase and the dopamine transporter. Elimination of the neo(r) cassette from the knock-in alleles partially restored TH and dopamine levels. The present neo(r)-positive TH hypomorphic mice show that nigrostriatal innervation develops independently of TH and should find use as a model for conditions of reduced catecholamine synthesis, as seen in, for example, L-dihydroxyphenylalanine-responsive dystonia/infantile parkinsonism.Keywords
Funding Information
- The Swedish Science Research Council
- Swedish Foundation for Strategic Research
- Fundação para a Ciência e Tecnologia (SFRH/BD/827/2000)
This publication has 30 references indexed in Scilit:
- Tyrosine hydroxylase deficiency: Clinical manifestations of catecholamine insufficiency in infancyMovement Disorders, 2002
- Distribution of bone morphogenetic protein and bone morphogenetic protein receptor transcripts in the rodent nervous system and up-regulation of bone morphogenetic protein receptor type II in hippocampal dentate gyrus in a rat model of global cerebral ischemiaNeuroscience, 2000
- BMP Type II Receptor Is Required for Gastrulation and Early Development of Mouse EmbryosDevelopmental Biology, 2000
- Potentiating interactions between morphogenetic protein and neurotrophic factors in developing neuronsJournal of Neuroscience Research, 1998
- BMPR-II expression and OP-1 effects in developing chicken retinal explantsNeuroReport, 1998
- Bone morphogenetic proteins and their receptors: Potential functions in the brainJournal of Neuroscience Research, 1998
- cDNA Cloning and Genomic Organization of the Mouse BMP Type II ReceptorBiochemical and Biophysical Research Communications, 1997
- Flp recombinase promotes site-specific DNA recombination in embryonic stem cells and transgenic mice.Proceedings of the National Academy of Sciences, 1996
- Expression of activin receptors type I and II only partially overlaps in the nervous systemNeuroReport, 1995
- Cloning of a Type I TGF-β Receptor and Its Effect on TGF-β Binding to the Type II ReceptorScience, 1993